Skip to main content
    U

    Utah Medical Products Inc (UTMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $72.36
    +0.39 (+0.54%)

    Market Cap: $204.92M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Utah Medical Products Inc (UTMD) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Utah Medical Products (UTMD) trades at 21.7x trailing earnings and 6.6x sales. Its P/E of 21.7x is above its 5-year median of 18.5x. Its forward P/E is 13.0x. The median P/E across 6 similar companies is 21.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 66.9% higher over the next year. Its free cash flow yield is 4.7%.

    MultipleValue
    P/E (trailing)21.7x
    Forward P/E13.0x
    Price to sales6.6x
    Price to book1.9x
    EV/EBITDA12.0x
    Price to FCF21.2x
    EV/FCF13.4x
    PEG4.3
    FCF yield4.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 8.0% above 20.1x, its P/S is in line and its P/B is 36.7% below 3.0x.

    MultipleCurrent5-year median10-year median
    P/E21.7x18.5x20.1x
    P/S6.6x5.8x6.6x
    P/B1.9x2.0x3.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 15.6x in 2024 to 28.0x in 2019.

    Year endPriceP/EP/SP/B
    2025$55.9616.1x4.7x1.5x
    2024$61.4715.6x5.3x1.8x
    2023$84.2218.4x6.1x2.4x
    2022$100.5322.3x7.0x3.2x
    2021$100.0024.7x7.4x3.4x
    2020$84.3015.8x7.3x3.0x
    2019$107.9028.0x8.6x4.0x
    2018$83.0820.4x7.4x3.5x
    2017$81.4020.8x7.3x3.9x
    2016$72.7523.2x7.0x3.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About UTMD

    What is UTMD's forward P/E ratio?

    Utah Medical Products has a forward P/E ratio of 13.0x.

    Is UTMD stock overvalued?

    GNG's valuation label for UTMD is Fairly valued. Its P/E of 21.7x compares with a median of 21.9x across 6 similar companies.

    What is UTMD's price to sales ratio?

    Utah Medical Products has a price to sales ratio of 6.6x.

    What is Utah Medical Products's average P/E ratio over 5 years?

    Utah Medical Products's median P/E over the last 5 years is 18.5x, from 60 month-end values through Oct 2026.

    What is UTMD's PEG ratio?

    Utah Medical Products has a PEG ratio of 4.3.